Stocks To Buy Now

Blog


DGE 13th Advancing Women’s Leadership in Pharma & Healthcare Conference, Philadelphia

Leaders of the pharma, biotech, and medical device healthcare industry, are invited to attend the 13th Advancing Women’s Leadership Skills & Opportunities In Pharma & Healthcare from September 23-25, 2024, in Philadelphia, PA.

This DGE program will focus on empowering women executives in leadership roles and closing the workplace gender gap. Success stories will be shared by women leaders who have succeeded after facing numerous career challenges. The event comprehensively offers insights into the life journeys of successful women, inspiring the attendees to overcome career hardships, achieve their goals, and seek the promotions they deserve.

The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing b2b events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

Important “how to” topics to be covered:

  • Strategies for Maneuvering the Landscape of the Board of Directors
  • Break Through the Promotional Pipeline
  • Cultivate Confidence – Tools to Improve Inner Belief and Executive Prescence
  • Overcome Obstacles for Women’s Success: Generational Perspectives
  • Maximize Opportunities to Shape Your Personal Brand
  • Embracing Authentic Leadership and Passing It On to Teams
  • Taking the High Road and Other Approaches for Getting Along at Work

The DGE conference includes keynote speaker sessions and discussion panels hosted by eminent industry leaders and women executives whose success journeys are an inspiration.

To know more, please visit https://ibn.fm/KMjev.

From Our Blog

D-Wave Quantum Inc. (NYSE: QBTS) and Japan Tobacco Complete Quantum AI Project Designed to Improve Drug Discovery Outcomes

April 25, 2025

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and the pharmaceutical division of Japan Tobacco Inc. (“JT”), have announced the successful completion of a proof-of-concept project applying quantum computing and artificial intelligence (“AI”) to drug discovery. The project demonstrated that a hybrid quantum-classical system outperformed classical methods in […]

Rotate your device 90° to view site.